Aluda Pharmaceuticals
October 16, 2023
Franciscan C
Platform for Therapeutics
Aluda Pharmaceuticals approaches drug discovery with a deep understanding of biology. Our domain is the signaling between and within cells that is central to immunological defense, inflammation and pathogenesis across many disease states.
We have a team with extensive experience in drug discovery and development through clinical phase II and bring specific knowledge of molecular design to our drugs.
Our programs include both new and previously explored drug targets, and we deploy best practices in discovery, from target validation and optimization to selection of leads and clinical strategies with highest ROI in the partnering marketplace.
Speaker(s)
Deebie Symmes
Headquarters Location
Menlo Park, California
Innovation Supporter
CLS FAST advisory program
Website
https://aludapharm.com/